| The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation. | |
| | |
MedLine Citation:
|
PMID: 20359855 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
BACKGROUND: Gallbladder carcinoma is known to be an aggressive malignancy and nonsensitive to routine chemotherapy. Its prognosis is quite poor. We have illustrated that somatostatin (SST) can enhance chemosensitivity of gallbladder cancer to Doxorubicin (DOX) in our precious studies. Here, we explored the possible mechanisms by which SST used to enhance the cytotoxicity of DOX on gallbladder carcinoma cell line. METHODS: Human gallbladder cancer cells line (GBC-SD cell line) were divided into four groups: control group, SST group, DOX group, SST+DOX co-treated-group. Cell cycle was detected by flow cytometry (FCM). Cell apoptosis index was detected by using Annexin V/Propidium Iodide Binding on FCM. The expressions of certain key cell cycle-related factors, including retinoblastoma protein (Rb) and E2F-1 protein were investigated by western blotting. ICBP90 protein, which could be a new downstream effector of E2F-1, was also detected by western blotting. The expression of Topo IIα protein, target enzyme of DOX, was assessed in synchronized GBC-SD cells by western blotting. RESULTS: After 24h treatment with SST alone, cell cycle was arrested at S phase in GBC-SD cells line, followed by indistinctive increment of apoptosis index. After 24h treatment with SST and DOX, apoptosis index significantly increased than that of DOX alone (P<0.05). Compared with control group, the expressions of Rb and E2F-1 protein were significantly up-regulated at 24h after treatment with SST. Similarly, the expressions of ICBP90 and Topo IIα protein were also enhanced at 24h after treatment with SST. CONCLUSION: These results suggested that SST could induce cell cycle block in S phase in GBC-SD cells line, the most sensitive phase of the cell cycle for DOX, through up-regulating Rb, E2F-1 and ICBP90 protein expression. Furthermore, ICBP90 induced the enhanced expression of Topo IIα protein which is the target enzyme of DOX and enhanced its cytotoxic effect on GBC-SD cells. We concluded that the mechanisms of SST enhanced chemosensitivity of GBC-SD cell line to DOX might be cell cycle arrest plus up-regulated target enzyme. |
| | |
Authors:
|
Zhi Wei Quan; Yong Yang; Ji Yu Li; Wei Gong; Yi Yu Qin; Song Gang Li |
Related Documents
:
|
19589995 - Cell growth and size homeostasis in proliferating animal cells. 10806485 - An encore for ribosome biogenesis in the control of cell proliferation. 1067615 - Temperature dependence of cycloheximide-sensitive phase of circadian cycle in acetabula... 20198345 - The cell cycle effects of docosahexaenoic acid on human metastatic hepatocellular carci... 22407755 - Xanthohumol induces different cytotoxicity and apoptotic pathways in malignant and norm... 21952585 - Possible role of visfatin in hepatoma progression and the effects of branched-chain ami... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-02-25 |
Journal Detail:
|
Title: Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie Volume: 64 ISSN: 1950-6007 ISO Abbreviation: Biomed. Pharmacother. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8213295 Medline TA: Biomed Pharmacother Country: France |
Other Details:
|
Languages: eng Pagination: 451-7 Citation Subset: IM |
Copyright Information:
|
2010 Elsevier Masson SAS. All rights reserved. |
Affiliation:
|
Department of General Surgery, Xinhua Hospital, School of medicine, Shanghai Jiaotong University, Shanghai 200092, PR China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in mice...
Next Document: Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic.